$51.96
-0.15 (-0.29%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+10.62%
1Y
+52.42%
YTD
+11.84%
Open$52.00
Previous Close$52.11
Day High$53.33
Day Low$51.49
52W High$65.00
52W Low$29.08
Volume—
Avg Volume1.46M
Market Cap7.43B
P/E Ratio—
EPS$-6.89
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$49.46
Above
SMA 200
$39.88
Above
RSI (14)
62.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
17 analysts
Price Target
+29.1% upside
Current
$51.96
$51.96
Target
$67.08
$67.08
$56.09
$67.08 avg
$108.72
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.07B | 3.02B | 2.41B |
| Net Income | 147.42M | 150.65M | 124.53M |
| Profit Margin | 4.8% | 5.0% | 5.2% |
| EBITDA | 264.93M | 279.22M | 238.21M |
| Free Cash Flow | 132.34M | 114.72M | 94.55M |
| Rev Growth | +1.9% | +8.9% | +10.2% |
| Debt/Equity | 1.24 | 1.35 | 1.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |